Accord BioPharma Partners with StoryMD to Deliver Advanced Prostate Cancer Educational Content to Clinicians and Patients
- Tuesday, September 20, 2022, 7:11
- Environment
- Add a comment
DURHAM, N.C., Sept. 20, 2022 /PRNewswire/ — Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced today a partnership with StoryMD. The StoryMD platform is a single, unified,…
About the Author
adminasapcorp has written 42182 stories on this site.